+ Direct Access

Are risk factors and impact of prevention strategies the same for early- and late-onset VAP?

Are risk factors and impact of prevention strategies the same for early- and late-onset VAP? EJRC Article Review   The risk factors and impact of prevention strategies for early-onset (EOP) versus late-onset (LOP) ventilator-associated pneumonia (VAP) are still under debate. Saied and colleagues conducted a retrospective analysis of data prospectively entered from 01/1997 to 03/2016 […]

Read More…

ICM ~ New ONLINE FIRST articles

ONLINE FIRST THIS WEEK (FREE ACCESS) ONLINE FIRST THIS WEEK   Conference Reports and Expert Panel ~ Jan J. De Waele et al. Antimicrobial resistance and antibiotic stewardship programmes in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance. Letter ~ James Downar et al. […]

Read More…

ICM ~ Ten Best Recent Articles

FREE ACCESS Yongfang Zhou et al. Early application of airway pressure release ventilation may reduce the duration of mechanical ventilation in acute respiratory distress syndrome. It was important to apply the physiology theoretical knowledge of APRV and the findings of recent experiment researches to standardise the APRV settings. The early use of the updated APRV methodology […]

Read More…

WHAT’S NEW IN ICM? (ONLINE FIRST)

~ NOVEMBER 18th 2016
[…]

Read More…

What can you do to halt AMR in your unit?

3 top strategies to fight antimicrobial resistance in the ICU   To support the 10th European Antibiotic Awareness Day and World Antiobiotic Awareness Week, November 13-19, the ANTARCTICA (ANTimicrobiAl Resistance CriTIcal CAre) – coalition, launched a call for increased awareness and action among intensive care and infectious diseases healthcare professionals to reduce antimicrobial resistance (AMR) […]

Read More…

Antimicrobial Resistance: CALL FOR ACTION

Facing the AMR challenge & providing solutions for critically ill patients 10th European Antibiotic Awareness Day Brussels, 15 November 2017. Patients in European intensive care units (ICUs) are increasingly suffering from infections caused by multidrug-resistant bacteria, which is associated with increased costs and worse outcome. The European Society of Intensive Care Medicine (ESICM) and the […]

Read More…

Prevention & Control of Multidrug-Resistant Gram-Negative Bacteria in ICUs

A Systematic Review and Network Meta-analysis EJRC Article Review Both the Healthcare Infection Control Practices Advisory Committee (2,3), the Centers for Disease Control & Prevention (6) and multiple other organisations (4,5) have published guidelines for the management of the increasing public health concern that is Multi-drug resistant Organisms. This is a meta-analysis into the effectiveness […]

Read More…

Biomarkers: A viable tool in fighting Invasive Candida infections?

EJRC Article Review Invasive Candida infections are leading causes of mortality among critically ill patients. The diagnosis of such diseases is challenging and a delayed start of the appropriate antifungal therapy was associated with a poor prognosis. Accordingly, early empirical antifungal treatment is warranted on the basis of suspected diagnosis. Observational studies have suggested that […]

Read More…

FUNGAL BIOMARKERS: RCT RESULTS

ARE FUNGAL BIOMARKERS USEFUL IN TREATING CANDIDA? Saad Nseir sits down with icTV to discuss the encouraging results from his recently published randomised control trial, which examined the use of a biomarker strategy for early discontinuation of empirical antifungal treatment in critically ill patients. Findings from this trial were presented for the first time publicly during […]

Read More…